Challenges and lessons learned from Covid-19 trials – should we be doing clinical trials differently?
release_mvjqk2m5mfhvlh7zxv2xzwtalu
by
Perrine Janiaud, Lars G. Hemkens, John Ioannidis
Cited By
References to this release by other works.Showing 1 - 2 of 2 references (in 70ms) | ||
---|---|---|
via fatcat-pubmed |
Characteristics and Research Waste Among Randomized Clinical Trials in Gastric Cancer
Jun Lu, Bin-bin Xu, Li-li Shen, Dong Wu, Zhen Xue, Hua-Long Zheng, Jian-Wei Xie, Jia-Bin Wang (+ more) 2021 JAMA Network Open doi:10.1001/jamanetworkopen.2021.24760 pmcid:PMC8449283 pmid:34533573 |
web.archive.org [PDF]
|
via crossref |
Randomized trials on non-pharmaceutical interventions for COVID-19 as of August 2021: a meta-epidemiological analysis
[post]
Julian Hirt, Perrine Janiaud, Lars G. Hemkens 2021 unpublished doi:10.1101/2021.08.20.21261687 |
web.archive.org [PDF]
|